Lung cancer is currently the most common cancer in the world, with 1,825,000 new cases diagnosed in recent years, accounting for 13% of all cancers. Therefore, annual lung cancer screening with the Cyfra 21-1 quantitative test is essential.

To screen, diagnose and treat all types of cancer, especially lung cancer, the quantitative test Cyfra 21-1 is necessary. In addition to the quantitative test of Cyfra 21-1, patients need ultrasound, X-ray, CT scan... to determine the specific condition and level of the disease.